PFS
MRNS

Prospera Financial Services’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Prospera Financial Services’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-41,144
Closed -$48.1K – 1207
2024
Q2 		$48.1K Buy
+41,144
New +$103K ﹤0.01% 1115

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Prospera Financial Services's MRNS Position: Q3 2024 in Review

Prospera Financial Services sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 41,144 shares — an estimated $48.1K sold.

Prospera Financial Services first reported a position in MRNS in Q2 2024 and held it in 1 quarter. The position peaked at $48.1K in Q2 2024. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

  • Prospera Financial Services reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
  • Prospera Financial Services sold 41,144 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $48.1K.
  • Prospera Financial Services first reported a position in Marinus Pharmaceuticals, Inc in Q2 2024 and held it in 1 quarter.
  • Prospera Financial Services's Marinus Pharmaceuticals, Inc position peaked at $48.1K in Q2 2024.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on Prospera Financial Services's 13F filing for Q3 2024, filed 7 Nov 2024.